BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6298814)

  • 1. Vitamin D and related research in osteogenesis imperfecta.
    Sbyrakis S; Mengreli C; Côté GB; Morakis A
    Prog Clin Biol Res; 1982; 104():367-76. PubMed ID: 6298814
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitamin D metabolism in osteogenesis imperfecta during calcitonin therapy.
    Nishi Y; Hyodo S; Yoshimitsu K; Sawano K; Yamaoka K; Seino Y; Usui T
    Pediatrics; 1984 Apr; 73(4):538-42. PubMed ID: 6546792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of patients with osteogenesis imperfecta.
    Albright JA; Grunt JA
    J Bone Joint Surg Am; 1971 Oct; 53(7):1415-25. PubMed ID: 5114704
    [No Abstract]   [Full Text] [Related]  

  • 4. Pyrophosphate levels and magnesium oxide therapy in osteogenesis imperfecta.
    Granda JL; Falvo KA; Bullough PG
    Clin Orthop Relat Res; 1977; (126):228-31. PubMed ID: 202425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Congenital osteogenesis imperfecta: clinical and biochemical evaluation in 80 children].
    Kulczycka H; Pronicka E; Ruszczak A; Stankiewicz B; Siwińska E; Sliwińska J; Lorenc R
    Pediatr Pol; 1987 Feb; 62(2):83-8. PubMed ID: 3615062
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic bone disease in children.
    Steendijk R
    Clin Orthop Relat Res; 1971; 77():247-75. PubMed ID: 4335242
    [No Abstract]   [Full Text] [Related]  

  • 7. [On fragilitas ossium hereditaria or Lobstein's disease (observations on 2 cases)].
    Zappata A; Mazzi C
    Ann Laringol Otol Rinol Faringol; 1968; 67(1):50-61. PubMed ID: 5757201
    [No Abstract]   [Full Text] [Related]  

  • 8. [Osteoporosis in thyroid disease].
    Mitsuma T
    Nihon Rinsho; 1990 Dec; 48(12):2898-903. PubMed ID: 2086852
    [No Abstract]   [Full Text] [Related]  

  • 9. Osteogenesis imperfecta: anthropometric, skeletal and mineral metabolic effects of long-term intravenous pamidronate therapy.
    Vallo A; Rodriguez-Leyva F; Rodríguez Soriano J
    Acta Paediatr; 2006 Mar; 95(3):332-9. PubMed ID: 16497645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical abnormalities.
    Burtis WJ; Lang R
    Orthop Clin North Am; 1984 Oct; 15(4):653-69. PubMed ID: 6093024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of synthetic salmon calcitonin in osteogenesis imperfecta.
    Castells S; Lu C; Baker RK; Wallach S
    Curr Ther Res Clin Exp; 1974 Jan; 16(1):1-14. PubMed ID: 4203843
    [No Abstract]   [Full Text] [Related]  

  • 12. [Correlation between hydroxyprolinuria, alkaline phosphatasemia and Ca45 dynamics].
    Gennari C; Rubegni M; Forconi S; Romano S
    Boll Soc Ital Biol Sper; 1965 May; 41(10):508-12. PubMed ID: 5875588
    [No Abstract]   [Full Text] [Related]  

  • 13. [Calcitonin and phosphate metabolism. Analysis of active calcium and phosphorus in children treated with Calcitar].
    Vulović D; Stojanov Lj; Nedeljković V; Banicević M; Zamurović D
    Srp Arh Celok Lek; 1977 Nov; 105(11):967-74. PubMed ID: 617001
    [No Abstract]   [Full Text] [Related]  

  • 14. [Collagen metabolism in osteogenesis imperfecta].
    Balaba TIa; Furtseva LN; Nefed'eva NN
    Vopr Med Khim; 1974; 20(5):471-6. PubMed ID: 4456796
    [No Abstract]   [Full Text] [Related]  

  • 15. Vitamin D and cyclic nucleotide changes in response to calcitonin in man.
    Nishi Y; Hyodo S; Usui T; Seino Y; Yamaoka K
    Hiroshima J Med Sci; 1985 Sep; 34(3):277-80. PubMed ID: 2999043
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biochemical studies on osteogenesis imperfecta].
    Langness U; Behnke H
    Dtsch Med Wochenschr; 1970 Jan; 95(5):213-4 passim. PubMed ID: 4243699
    [No Abstract]   [Full Text] [Related]  

  • 17. Osteogenesis imperfecta: effect of magnesium administration on pyrophosphate metabolism.
    Solomons CC; Styner J
    Calcif Tissue Res; 1969; 3(4):318-26. PubMed ID: 4310540
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of porcine calcitonin therapy on vitamin D metabolism and clinical response in a patient with osteogenesis imperfecta.
    Nishi Y; Hyodo S; Ishida M; Yamaoka K; Seino Y; Usui T
    Acta Paediatr Scand; 1983 Jan; 72(1):149-52. PubMed ID: 6858681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative evaluation of biological activity of 1 alpha,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol in rats].
    Alekseeva IA; Spiricheva VB; Blazhevich NV; Sokolova SV; Pereverzeva OG
    Vopr Med Khim; 1982; 28(5):71-8. PubMed ID: 6983777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vitamin-resistant rickets. (Presentation of a case)].
    Pridie G; Maga I; Ludu M; Ilea I; Pogany E; Rotaru A
    Pediatria (Bucur); 1968; 17(4):335-41. PubMed ID: 5701384
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.